Molecular assays developer NEUMANN Diagnostics Ltd. today unveiled its CONFIDENCE™ molecular test portfolio setting a new standard in cervical cancer screening.
Forrás: PRNEWSWIRE : teljes cikk >>
Molecular assays developer NEUMANN Diagnostics Ltd. today unveiled its CONFIDENCE™ molecular test portfolio setting a new standard in cervical cancer screening.
Forrás: PRNEWSWIRE : teljes cikk >>